Healthcare Stocks Among Worst Performers -- Healthcare Roundup

Dow Jones

04-16

Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2.

Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies.

J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs.

Write to Paulo Trevisani at paulo.trevisani@wsj.com

(END) Dow Jones Newswires

April 15, 2025 17:01 ET (21:01 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2527047808"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527047808\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2527047808?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-16 05:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527047808","market":"hk","top_or_hot":-1,"title":"Healthcare Stocks Among Worst Performers -- Healthcare Roundup","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n</p>\n<p>\n  Johnson &amp; Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n</p>\n<p>\n  J&amp;J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 15, 2025 17:01 ET (21:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare Stocks Among Worst Performers -- Healthcare Roundup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare Stocks Among Worst Performers -- Healthcare Roundup\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-16 05:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n</p>\n<p>\n  Johnson &amp; Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n</p>\n<p>\n  J&amp;J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 15, 2025 17:01 ET (21:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"综合支持服务","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527047808","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527047808","pubTimestamp":1744750860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2.Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies.J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","HCSG":"医疗保健服务"},"translate_title":"医疗保健股是表现最差的股票之一——医疗保健综述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1},"content_text":"Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n\n\n  Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n\n\n  J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n\n\n \n\n\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  April 15, 2025 17:01 ET (21:01 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}